NUVBX
Price
$8.55
Change
-$0.09 (-1.04%)
Updated
Apr 11 closing price
Net Assets
7.69B
VWITX
Price
$13.16
Change
-$0.12 (-0.90%)
Updated
Apr 11 closing price
Net Assets
77.77B
Ad is loading...

NUVBX vs VWITX

Header iconNUVBX vs VWITX Comparison
Open Charts NUVBX vs VWITXBanner chart's image
Nuveen Intermediate Duration Muni Bd I
Price$8.55
Change-$0.09 (-1.04%)
VolumeN/A
Net Assets7.69B
Vanguard Interm-Term Tx-Ex I
Price$13.16
Change-$0.12 (-0.90%)
VolumeN/A
Net Assets77.77B
NUVBX vs VWITX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NUVBX vs. VWITX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVBX is a Hold and VWITX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VWITX has more cash in the bank: 77.8B vs. NUVBX (7.69B). NUVBX (3.24) and VWITX (3.09) have matching dividends . NUVBX was incepted earlier than VWITX: NUVBX (48 years) vs VWITX (48 years). NUVBX (0.45) is less costly to investors than VWITX (0.17). VWITX is a more actively managed with annual turnover of: 31.00 vs. NUVBX (24.00). VWITX has a lower initial minimum investment than NUVBX: VWITX (3000) vs NUVBX (100000). NUVBX annual gain was more profitable for investors over the last year : 1.38 vs. VWITX (-1.85). NUVBX return over 5 years is better than : 6.43 vs. VWITX (-7.00).
NUVBXVWITXNUVBX / VWITX
Total Expense Ratio0.450.17265%
Annual Report Gross Expense Ratio0.450.17265%
Fund Existence48 years48 years-
Gain YTD-1.013-2.13747%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets7.69B77.8B10%
Annual Yield % from dividends3.243.09105%
Returns for 1 year1.38-1.85-75%
Returns for 3 years5.08-2.50-203%
Returns for 5 years6.43-7.00-92%
Returns for 10 years13.07-6.61-198%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX18.26N/A
N/A
Saratoga Health & Biotechnology A
FEVAX20.33N/A
N/A
First Eagle US A
LGOQX18.92N/A
N/A
Lord Abbett Growth Opportunities R2
TASCX16.30N/A
N/A
Third Avenue Small Cap Value Instl
OEGIX28.57N/A
N/A
Invesco Discovery Mid Cap Growth R6